The activation of phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) axis and mitogen-activated protein kinase by growth factor signaling is one of the main factors resulting in ET resistance in BC. This evidence concerns the gene AKT1 and breast cancer.